Trial intelligence / Profile preview

Tazarotene and Betamethasone Dipropionate Cream in Chronic Plaque Psoriasis

CTR20160731Phase 4Completed

Sponsor
Huabang Pharmaceutical
Start
Sep 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tazarotene + betamethasone dipropionate in psoriasis, sponsored by Huabang Pharmaceutical. Started Sep 2016; status: completed.

02

Drugs

tazarotene + betamethasone dipropionate
03

Conditions

psoriasis

Beyond the preview

Go deeper on CTR20160731.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20160731.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call